Skip to main content

Table 4 Patients’ clinical characteristics at sixth month

From: Effects of hydrophilic polymer-coated polysulfone membrane dialyzers on intradialytic hypotension in diabetic hemodialysis patients (ATHRITE BP Study): a pilot study

  NV group PS/PES group P
BMI (kg/m2) 24.0 ± 5.0 24.8 ± 4.2 0.57
White blood cell count (×103/μL) 6.1 ± 2.0 6.7 ± 2.3 0.37
Hemoglobin (g/dL) 10.6 ± 2.5 10.8 ± 0.9 0.75
Platelet (×104/μL) 18.6 ± 5.0 18.2 ± 4.7 0.84
ESA user (%) 16 (80%) 15 (75%) 0.71
Ferritin (ng/mL) 104.6 ± 88.1 88.3 ± 55.6 0.50
Phosphate (mg/dL) 5.8 ± 1.1 5.2 ± 0.9 0.10
Calcium (mg/dL) 8.9 ± 0.7 8.9 ± 0.6 1.00
Intact PTH (ng/mL) 154 ± 121 161 ± 152 0.87
Albumin (g/dL) 3.5 ± 0.3 3.5 ± 0.2 0.96
Total-cholesterol (mg/dL) 169 ± 31 157 ± 29 0.20
Triglyceride (mg/dL) 119 ± 60 155 ± 115 0.22
HDL-cholesterol (mg/dL) 45 ± 12 45 ± 13 0.92
Ankle brachial index (right) 1.00 ± 0.28 1.11 ± 0.25 0.33
Ankle brachial index (left) 1.00 ± 0.28 1.08 ± 0.23 0.33
Homocysteine (nmol/mL) 34.5 ± 17.6 29.6 ± 12.0 0.31
Pentosidine (μg/mL) 0.399 ± 0.177 0.351 ± 0.184 0.40
hsCRP (mg/dL) 0.179 ± 0.191 0.212 ± 0.201 0.60
Pentraxin 3 (ng/mL) 4.47 ± 2.12 3.71 ± 2.51 0.31
Adrenaline (ng/mL) 0.02 ± 0.01 0.02 ± 0.01 0.81
Noradrenaline (ng/mL) 0.44 ± 0.24 0.41 ± 0.19 0.73
Dopamine (ng/mL) 0.04 ± 0.02 0.06 ± 0.04 0.15
  1. BMI body mass index, ESA erythropoiesis-stimulating agent, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein